1. Home
  2. CRNX vs FIBK Comparison

CRNX vs FIBK Comparison

Compare CRNX & FIBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$33.65

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo First Interstate BancSystem Inc. (DE)

FIBK

First Interstate BancSystem Inc. (DE)

HOLD

Current Price

$32.82

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
FIBK
Founded
2008
1879
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
CRNX
FIBK
Price
$33.65
$32.82
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$74.78
$36.71
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
5.61%
EPS Growth
N/A
34.25
EPS
N/A
2.94
Revenue
$1,039,000.00
N/A
Revenue This Year
$722.66
N/A
Revenue Next Year
$183.79
$4.89
P/E Ratio
N/A
$11.40
Revenue Growth
N/A
N/A
52 Week Low
$24.10
$22.95
52 Week High
$57.99
$39.26

Technical Indicators

Market Signals
Indicator
CRNX
FIBK
Relative Strength Index (RSI) 29.20 38.42
Support Level $33.23 $31.37
Resistance Level $37.23 $32.93
Average True Range (ATR) 1.62 0.84
MACD 0.13 0.10
Stochastic Oscillator 8.33 37.01

Price Performance

Historical Comparison
CRNX
FIBK

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About FIBK First Interstate BancSystem Inc. (DE)

First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.

Share on Social Networks: